| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 铁屎米酮; Canthin-6-one | CFN98730 | 479-43-6 | C14H8N2O = 220.2 | 5mg | QQ客服：3257982914 |
| 去甲肾上腺素; Norepinephrine | CFN90047 | 51-41-2 | C8H11NO3 = 169.18 | 20mg | QQ客服：1413575084 |
| 3-硝基-L-酪氨酸; 3-Nitro-L-tyrosine | CFN90054 | 621-44-3 | C9H10N2O5 = 226.19 | 20mg | QQ客服：2056216494 |
| 3-硝基-L-酪氨酸乙酯盐酸盐; 3-Nitro-L-tyrosine ethyl ester hydrochloride | CFN90055 | 66737-54-0 | C11H15ClN2O5 = 290.7 | 5mg | QQ客服：1413575084 |
| NG，NG二甲基精氨酸盐酸盐; NG,NG-Dimethylarginine dihydrochloride | CFN90056 | 220805-22-1 | C8H20Cl2N4O2 = 275.18 | 5mg | QQ客服：2159513211 |
| 千里光非灵; Seneciphylline | CFN98747 | 480-81-9 | C18H23NO5 = 333.4 | 5mg | QQ客服：215959384 |
| 萨杷晋碱; Sarpagine | CFN98759 | 482-68-8 | C19H22N2O2 = 310.4 | 5mg | QQ客服：2159513211 |
| 阿立新碱; Aricine | CFN98760 | 482-91-7 | C22H26N2O4 = 382.5 | 5mg | QQ客服：3257982914 |
| 萝巴新； 阿吗碱; Ajmalicine | CFN98761 | 483-04-5 | C21H24N2O3 = 352.4 | 5mg | QQ客服：2056216494 |
| 异柯楠碱; Isorauhimbine | CFN98762 | 483-09-0 | C21H26N2O3 = 354.5 | 5mg | QQ客服：215959384 |
| 核黄素; Riboflavine | CFN90067 | 83-88-5 | C17H20N4O6 = 376.36 | 20mg | QQ客服：2056216494 |
| 盐酸硫胺; Thiamine hydrochloride | CFN90068 | 67-03-8 | C12H18Cl2N4OS = 337.27 | 20mg | QQ客服：3257982914 |
| 3,3',5-三碘-L-甲腺原氨酸钠盐; 3,3'',5-Triiodo-L-thyronine Sodium Salt | CFN90069 | 55-06-1 | C15H11I3NNaO4 = 672.96 | 20mg | QQ客服：215959384 |
| 犬尿喹啉酸; Kynurenic acid | CFN90072 | 492-27-3 | C10H7NO3 = 189.17 | 20mg | QQ客服：2056216494 |
| S-(5'-腺苷基)-L-氯化蛋氨酸; S-(5'-Adenosyl)-L-methionine chloride | CFN90073 | 24346-00-7 | C15H23ClN6O5S = 434.9 | 10mg | QQ客服：1413575084 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)